Preclinical evaluation of radiolabeled peptides for PET imaging of glioblastoma multiforme

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F19%3A73598665" target="_blank" >RIV/61989592:15110/19:73598665 - isvavai.cz</a>

Result on the web

<a href="https://www.mdpi.com/1420-3049/24/13/2496/htm" target="_blank" >https://www.mdpi.com/1420-3049/24/13/2496/htm</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3390/molecules24132496" target="_blank" >10.3390/molecules24132496</a>

Result language

angličtina

Original language name

Preclinical evaluation of radiolabeled peptides for PET imaging of glioblastoma multiforme

Original language description

Glioblastoma multiforme (GBM) is an aggressive primary brain tumor and, despite the current intensive therapy regimen, median overall survival period is only 16–21 months from the date of diagnosis. Therefore, early and precise diagnosis of GBM is a key aspect for appropriate patient care approach. Imaging techniques play an important role in the diagnosis of GBM and subsequent disease monitoring.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

10608 - Biochemistry and molecular biology

Project

Result was created during the realization of more than one project. More information in the Projects tab.

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2019

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

MOLECULES

ISSN

1420-3049

e-ISSN

—

Volume of the periodical

2019

Issue of the periodical within the volume

24

Country of publishing house

CH - SWITZERLAND

Number of pages

14

Pages from-to

"nestránkováno"

UT code for WoS article

000476700300150

EID of the result in the Scopus database

—